Skip to main content
. Author manuscript; available in PMC: 2020 Apr 22.
Published in final edited form as: J Virol Methods. 2018 Jun 30;260:26–33. doi: 10.1016/j.jviromet.2018.06.018

Fig. 1.

Fig. 1.

(a–e) Show the relationship between days post-onset of symptoms (DPO) and kit results for samples that tested ZIKV IgM-positive using reference methods. Numbers of samples tested at each time point are listed on the y-axis. Results in Fig. 1a for InBios ZIKV Detect™ IgM Capture ELISA were generated using serum Panels 1 and 2; results in Fig. 1b. for NovaTec NovaLisa® Zika Virus IgM μ-capture ELISA were generated using Panels 1, 2 and 3, where equivocals were classified as Zika Positive; results for Euroimmun Anti-Zika Virus ELISA IgM and IgG (Fig. 1c-e) were generated using Panel 1, where borderlines were classified as Zika Positive.